Vaccine Shows Promise for Preventing Active TB Disease - NECN

Vaccine Shows Promise for Preventing Active TB Disease

About one-third of the world's people harbor the bacteria that cause tuberculosis

    processing...

    NEWSLETTERS

    Vaccine Shows Promise for Preventing Active TB Disease
    Junior Kannah/AFP/Getty Images
    In this Sept. 10, 2015, photo, women hold their babies as they wait for them to be vaccinated with the BCG vaccine against tuberculosis at a Noki health center in the Democratic Republic of the Congo.

    An experimental vaccine proved 50% effective at preventing latent tuberculosis infection from turning into active disease in a three-year study of adults in Africa.

    Doctors were encouraged because protection declined only a little after two years, and even a partially effective vaccine would be a big help against TB. The lung disease kills more than a million people a year, mostly in poor countries, and about one-third of the world's people harbor the bacteria that cause it.

    Results were reported Tuesday at a conference in India, the country hardest hit by TB, and published by the New England Journal of Medicine.

    There is a TB vaccine now, but it's given only to very young children and partly prevents severe complications. Researchers have been seeking a vaccine that also works in adults, to curb spread of the disease.

    Trapped Hong Kong Protesters Rappel Down Hoses to Escape

    [NATL] Trapped Hong Kong Protesters Rappel Down Hoses to Escape

    Harrowing footage shows protesters trapped inside Hong Kong Polytechnic University rappelling down hoses to escape a police siege. About 100 anti-government protesters remain inside the university on a third day of clashes between protesters and police. 

    (Published Tuesday, Nov. 19, 2019)

    GlaxoSmithKline's experimental vaccine was tested in nearly 3,600 adults in Kenya, South Africa and Zambia who were infected with TB but who did not also have HIV, the virus that causes AIDS.

    Half were given two doses of vaccine a month apart and the rest got dummy shots. Thirteen people in the vaccine group and 26 in the other group developed active TB.

    The new results show that "the vaccine is holding up" over time, and mark an important step toward having a prevention tool that's been sought for 100 years, said Dr. Paula Fujiwara, scientific director of the International Union Against Tuberculosis and Lung Disease, the group hosting the conference in Hyderabad, India.

    Plans are underway for another, definitive study, which will take at least several more years, she said.

    After two-year results were announced last year, the World Health Organization called the vaccine a major breakthrough and has been holding meetings to discuss how to further its development.

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

    Melting Sea Ice Spurs Spread of Marine Diseases

    [NATL] Melting Sea Ice Spurs Spread of Marine Diseases

    Melting sea ice on its own presents plenty of challenges for Arctic marine mammals, from loss of habitat, to changing predator prey dynamics. Now there's a new challenge present in a link between sea ice loss and the spread of disease between previously isolated marine life.

    (Published Tuesday, Nov. 19, 2019)